Twist Bioscience Corp Net Income Loss

• Twist Bioscience Corp showed an increase of +62.8% in Net Income Loss from 2024 to 2025.
• This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 17, 2025.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Twist Bioscience Corp's Net Income Loss has declined by 31.0%.
• Historical annual values: Fiscal year 2025: -$77.67 million | Fiscal year 2024: -$208.73 million | Fiscal year 2023: -$204.62 million | Fiscal year 2022: -$217.86 million | Fiscal year 2021: -$152.10 million | Fiscal year 2020: -$139.93 million | Fiscal year 2019: -$107.67 million | Fiscal year 2018: -$71.24 million | Fiscal year 2017: -$59.31 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026